4.2 Article

Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Ketorolac 0.45% Ophthalmic Solution

Paul L. McCormack

DRUGS & AGING (2011)

Review Ophthalmology

Difluprednate for the prevention of ocular inflammation postsurgery: an update

Eric D. Donnenfeld

CLINICAL OPHTHALMOLOGY (2011)

Review Ophthalmology

Nonsteroidal Anti-inflammatory Drugs in Ophthalmology

Stephen J. Kim et al.

SURVEY OF OPHTHALMOLOGY (2010)

Article Ophthalmology

Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain

Michael S. Korenfeld et al.

JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2009)

Editorial Material Ophthalmology

Visual Loss Caused by Corticosteroid-Induced Glaucoma: How to Avoid It

George L. Spaeth et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)

Review Ophthalmology

Treatment of ocular inflammatory conditions with loteprednol etabonate

C. E. Pavesio et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2008)

Review Public, Environmental & Occupational Health

Locally administered ocular corticosteroids - Benefits and risks

CNJ McGhee et al.

DRUG SAFETY (2002)

Article Ophthalmology

Control of intra-ocular inflammation associated with cataract surgery

Sherif M. El-Harazi et al.

CURRENT OPINION IN OPHTHALMOLOGY (2001)